The latest research in CTDs and Mast Cell disorders, listed from most recent (top of list) to older resources (bottom of list).
Listings include a link embedded in the name of the study, the year it was published, and a credit to the group member who shared it with us.
Note: under construction, please check back!
Image credit: Vortioxetine, Two mast cells in bone marrow, CC BY-SA 4.0 via Wikimedia Commons
Sublingual Immunotherapy (SLIT) May Result in Desensitization and Remission for Peanut-Allergic Children, PRNewswire/SnackSafely newsletter, October 2023, via Jon R
Safety and technical success of diphenhydramine as an alternative local anaesthetic agent for radiology procedures, Indications were history of severe allergy to “-caine” local anaesthetics; injectable diphenhydramine appears to be a safe and effective local anaesthetic alternative in patients with “-caine” class contraindications undergoing radiology procedures. PubMed March 2023, via Jane Y.
Polymers Help Protect Mice from Anaphylactic Reaction to Peanuts, UChicago Research Finds, 2023 via Jon R.
Bryn Pharma Completes Study of Nasal Epinephrine vs Auto-Injector for Anaphylaxis, September 2022 via Jon R.
Food allergies can be reversed in mice by targeting the microbiome, American Chemical Society’s EurekAlert, August 2022 via Jane Y.
Mast cell disorders are associated with decreased cerebral blood flow and small fiber neuropathy, Annals of Allergy, Asthma & Immunology, March 2022 via Pilar GD
Mast Cell Disorders in Ehlers–Danlos Syndrome 2017 via PGD
EDS and CTD New England/MA Support Group 
Leave a comment